Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Kao, Patricia F ^a   Davis, David A ^a   Banigan, Meredith G ^b   Vanderburg, Charles R ^b   Seshadri, Sudha ^a   Delalle, Ivana ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; MESSENGER RNA; PROTEIN CAPZ; PROTEIN CAPZ BETA2 SUBUNIT; UNCLASSIFIED DRUG; ACTIN CAPPING PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; AUTOPSY; CELL STRUCTURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MICROTUBULE ASSEMBLY; MICROTUBULE ORGANIZING CENTER; NERVE CELL PLASTICITY; NEUROMODULATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; WESTERN BLOTTING; AGED; CYTOSKELETON; FEMALE; GENE SILENCING; GENETICS; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY;

ACTIN CAPPING PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CYTOSKELETON; FEMALE; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; NEURONS; RNA, MESSENGER;

EID: 78149463046     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013337     Document Type: Article

References (48)

1. McMurray CT (2000) Neurodegeneration: diseases of the cytoskeleton? Cell Death Differ 7: 861-865.
2. Li Y, Grupe A (2007) Genetics of late-onset Alzheimer's disease: progress and prospect. Pharmacogenomics 8: 1747-1755.
3. Arendt T, Schindler C, Bruckner MK, Eschrich K, Bigl V, et al. (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17: 516-529.
4. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, et al. (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270: 19791-19799.
5. Sabo SL, Ikin AF, Buxbaum JD, Greengard P (2003) The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci 23: 5407-5415.
6. Spira ME, Oren R, Dormann A, Gitler D (2003) Critical calpain-dependent ultrastructural alterations underlie the transformation of an axonal segment into a growth cone after axotomy of cultured Aplysia neurons. J Comp Neurol 457: 293-312.
7. Mejillano MR, Kojima S, Applewhite DA, Gertler FB, Svitkina TM, et al. (2004) Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end. Cell 118: 363-373.
8. Schafer DA, Korshunova YO, Schroer TA, Cooper JA (1994) Differential localization and sequence analysis of capping protein beta-subunit isoforms of vertebrates. J Cell Biol 127: 453-465.
9. Davis DA, Wilson MH, Giraud J, Xie Z, Tseng HC, et al. (2009) Capzb2 interacts with beta-tubulin to regulate growth cone morphology and neurite outgrowth. PLoS Biol 7: e1000208.
10. Nelson TJ, Backlund PS, Jr., Alkon DL (2004) Hippocampal protein-protein interactions in spatial memory. Hippocampus 14: 46-57.
11. Kitanishi T, Sakai J, Kojima S, Saitoh Y, Inokuchi K, et al. (2010) Activitydependent localization in spines of the F-actin capping protein CapZ screened in a rat model of dementia. Genes Cells 15: 737-747.
12. Linnarsson S, Bjorklund A, Ernfors P (1997) Learning deficit in BDNF mutant mice. Eur J Neurosci 9: 2581-2587.
13. Schaaf MJ, Workel JO, Lesscher HM, Vreugdenhil E, Oitzl MS, et al. (2001) Correlation between hippocampal BDNF mRNA expression and memory performance in senescent rats. Brain Res 915: 227-233.
14. Croll SD, Ip NY, Lindsay RM, Wiegand SJ (1998) Expression of BDNF and trkB as a function of age and cognitive performance. Brain Res 812: 200-208.
15. Wu A, Ying Z, Gomez-Pinilla F (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155: 751-759.
16. Rex CS, Lin CY, Kramar EA, Chen LY, Gall CM, et al. (2007) Brain-derived neurotrophic factor promotes long-term potentiation-related cytoskeletal changes in adult hippocampus. J Neurosci 27: 3017-3029.
17. Lu Y, Christian K, Lu B (2008) BDNF: a key regulator for protein synthesisdependent LTP and long-term memory? Neurobiol Learn Mem 89: 312-323.
18. Goutan E, Marti E, Ferrer I (1998) BDNF, and full length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and cell-specific responses. Brain Res Mol Brain Res 59: 154-164.
19. Avwenagha O, Campbell G, Bird MM (2003) Distribution of GAP-43, beta-III tubulin and F-actin in developing and regenerating axons and their growth cones in vitro, following neurotrophin treatment. J Neurocytol 32: 1077-1089.
20. McKee AC, Kowall NW, Kosik KS (1989) Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann Neurol 26: 652-659.
21. Miyamoto Y, Yamauchi J, Tanoue A, Wu C, Mobley WC (2006) TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology. Proc Natl Acad Sci U S A 103: 10444-10449.
22. Luo L (2000) Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 1: 173-180.
23. Gutala RV, Reddy PH (2004) The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Methods 132: 101-107.
24. Fujimura RK, Reiner T, Ma F, Phillips V, de las Pozas A, et al. Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease. J Alzheimers Dis 19: 97-109.
25. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, et al. (1991) BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7: 695-702.
26. Connor B, Young D, Yan Q, Faull RL, Synek B, et al. (1997) Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 49: 71-81.
27. Connor B, Young D, Lawlor P, Gai W, Waldvogel H, et al. (1996) Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res 42: 1-17.
28. Braak H, Braak E (1997) Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 18: S85-88.
29. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML (2004) Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33: 377-387.
30. Scheibel AB (1979) Dendritic changes in senile and presenile dementias. Res Publ Assoc Res Nerv Ment Dis 57: 107-124.
31. Nichols NR, Day JR, Laping NJ, Johnson SA, Finch CE (1993) GFAP mRNA increases with age in rat and human brain. Neurobiol Aging 14: 421-429.
32. Beach TG, Walker R, McGeer EG (1989) Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 2: 420-436.
33. Price JL, McKeel DW, Jr., Buckles VD, Roe CM, Xiong C, et al. (2009) Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 30: 1026-1036.
34. Suzuki S, Numakawa T, Shimazu K, Koshimizu H, Hara T, et al. (2004) BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J Cell Biol 167: 1205-1215.
35. Alonso M, Vianna MR, Depino AM, Mello e Souza T, Pereira P, et al. (2002) BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12: 551-560.
36. Poon WW, Blurton-Jones M, Tu CH, Feinberg LM, Chabrier MA, et al. (2009) beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging Jun 18;Available: doi:10.1016/j.neurobiolaging.2009.05.012.
37. Peng S, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brainderived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93: 1412-1421.
38. Angelucci F, Spalletta G, di Iulio F, Ciaramella A, Salani F, et al. (2010) Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels. Curr Alzheimer Res 7: 15-20.
39. Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, et al. (2006) Stagedependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 113: 1217-1224.
40. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, et al. (2003) Leisure activities and the risk of dementia in the elderly. N Engl J Med 348: 2508-2516.
41. Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, et al. (2006) Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144: 73-81.
42. Pasinetti GM, Zhao Z, Qin W, Ho L, Shrishailam Y, et al. (2007) Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. Interdiscip Top Gerontol 35: 159-175.
43. Knaepen K, Goekint M, Heyman EM, Meeusen R (2010) Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med 40: 765-801.
44. Rossi C, Angelucci A, Costantin L, Braschi C, Mazzantini M, et al. (2006) Brainderived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur J Neurosci 24: 1850-1856.
45. Duan W, Lee J, Guo Z, Mattson MP (2001) Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci 16: 1-12.
46. Kuzumaki N, Ikegami D, Tamura R, Sasaki T, Niikura K, et al. (2010) Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging. Synapse 64: 611-616.
47. Berchtold NC, Castello N, Cotman CW (2010) Exercise and time-dependent benefits to learning and memory. Neuroscience 167: 588-597.
48. Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, et al. (2010) Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol 69: 70-81.